Adverse event/effect(s): 5. Specific ‐ movement disorder ‐ average score (SAS, endpoint, high = poor, skewed data) | ||||||
---|---|---|---|---|---|---|
Study | Mean (Modafinil group) | SD (Modafinil group) | N (Modafinil Group) | Mean (Placebo group) | SD (Placebo group) | N (Placebo group) |
Lohr 2013 | 4.1 | 3.46 | 12 | 5.3 | 4.5 | 12 |
Sevy 2005 | 0.3 | 0.7 | 10 | 0.6 | 1.1 | 10 |
Shafti 2016 | 5.71 | 3.39 | 25 | 5.98 | 4.01 | 25 |